3F-PCP
3F-PCP is a synthetic dissociative substance of the arylcyclohexylamine class. It is a fluorinated analog of phencyclidine (PCP), in which a fluorine atom is substituted at the 3-position of the phenyl ring. First identified in Slovenia in October 2020, it emerged as a novel designer drug. As a relatively new research chemical, limited data is available regarding its pharmacological profile, safety, and long-term health effects.
Contents
Dosage & Duration
Subjective Effects
Reagent Testing
Loading reagent data
Pharmacology
Pharmacodynamics
Pharmacokinetics
Tolerance
Harm Potential
History & Culture
3F-PCP is a relatively recent addition to the novel dissociative market. The compound was first analytically identified in Slovenia in October 2020, marking its initial detection by drug monitoring services. As a designer arylcyclohexylamine, it emerged as part of the ongoing development of novel phencyclidine derivatives intended for recreational use.
Trip Reports
Loading related reports
Preparing section content
Still loading. Refresh if this section does not appear.
Legality
By Country
References
Source Pages
Further Reading
CFSRE: Toxicology Monograph - F-PCP
Cone et al. (1984) - Structure-Activity Studies PCP Derivatives
GlpBio - 3-Fluoro-PCP Analytical Standard- Morris & Wallach (2014) - PCP to MXE Comprehensive Review
Reddit: r/dissociatives - 3F-PCP Oral vs Intranasal- Reddit: r/researchchemicals - 3F-PCP Extensive Overview
Slovenian National Forensic Lab - 3F-PCP Analytical Report (2020)
Structure-activity study of PCP derivatives
Syntheses of fluorinated phencyclidine analogs- Syntheses of Fluorinated Phencyclidine Analogues
- Wallach et al. (2014) - Structure-Activity PCP Derivatives
Automated synthesisInformation aggregated and synthesized using an autonomous workflow built by Josie Kins.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the 3F-PCP article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
